Researchers from Trinity College London has developed a new vaccine that can prevent blindness due to age which usually experienced by elderly. This new study itself was published in the journal Nature Medicine.
Age-related macular degeneration (AMD) is a small area of damage in retina called the macula. Though small, the macula allows you to see detail something obvious. Unfortunately this disease is one of the leading cause of blindness among older adults and affects more than a quarter of the elderly population aged over 60 years.
Even the number of sufferers is expected to increase three-fold in the next 25 years. But at that time researchers from Trinity College London has had potential treatment after succeed developing a chemical known as IL-18. These chemicals can prevent worsening of the condition known as AMD.
Age-related macular degeneration (AMD) is a small area of damage in retina called the macula. Though small, the macula allows you to see detail something obvious. Unfortunately this disease is one of the leading cause of blindness among older adults and affects more than a quarter of the elderly population aged over 60 years.
Even the number of sufferers is expected to increase three-fold in the next 25 years. But at that time researchers from Trinity College London has had potential treatment after succeed developing a chemical known as IL-18. These chemicals can prevent worsening of the condition known as AMD.
